Agilon Health Inc (AGL)
4.53 x 8 4.59 x 1
Post-market by (Cboe BZX)
4.53 +0.43 (+10.49%) 03/21/25 [NYSE]
4.53 x 8 4.59 x 1
Post-market 4.54 +0.01 (+0.22%) 19:29 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 6,060,530 | 4,316,363 | 2,388,220 | 1,521,494 | 1,218,333 |
Cost of Goods | 6,055,689 | 4,246,693 | 2,276,860 | 1,455,750 | 1,124,183 |
Gross Profit | 4,841 | 69,670 | 111,360 | 65,744 | 94,150 |
Operating Expenses | 297,660 | 302,496 | 217,598 | 438,736 | 151,006 |
Operating Income | -292,130 | -232,133 | -105,378 | -372,242 | -56,673 |
Interest Expense | 6,177 | 6,658 | 4,484 | 6,146 | 8,135 |
Other Income | 49,481 | 44,329 | 19,192 | -4,588 | 2,465 |
Pre-tax Income | -248,826 | -194,462 | -90,670 | -382,976 | -62,343 |
Income Tax | 1,451 | 791 | 1,640 | 886 | 865 |
Net Income Continuous | -250,277 | -195,253 | -92,310 | -383,862 | -63,208 |
Net Income Discontinuous | -9,824 | -67,550 | -14,554 | -22,925 | 3,156 |
Minority Interests | 50 | -207 | -311 | -300 | N/A |
Net Income | $-260,151 | $-262,596 | $-106,553 | $-406,487 | $-60,052 |
EPS Basic Total Ops | -0.63 | -0.64 | -0.26 | -1.09 | -0.19 |
EPS Basic Continuous Ops | -0.61 | -0.48 | -0.22 | -1.03 | -0.20 |
EPS Basic Discontinuous Ops | -0.02 | -0.16 | -0.04 | -0.06 | 0.01 |
EPS Diluted Total Ops | -0.63 | -0.64 | -0.26 | -1.09 | -0.19 |
EPS Diluted Continuous Ops | -0.61 | -0.48 | -0.22 | -1.03 | -0.20 |
EPS Diluted Discontinuous Ops | -0.02 | -0.16 | -0.04 | -0.06 | 0.01 |
EPS Diluted Before Non-Recurring Items | -0.60 | -0.46 | -0.26 | -0.36 | N/A |
EBITDA(a) | $-267,667 | $-211,972 | $-91,606 | $-357,572 | $-42,574 |